{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T15:28:34Z","timestamp":1791300514410,"version":"4.1.0"},"reference-count":42,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T00:00:00Z","timestamp":1504224000000},"content-version":"vor","delay-in-days":731,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"name":"JSPS KAKENHI","award":["25461151"],"award-info":[{"award-number":["25461151"]}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","resmedjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Respiratory Medicine"],"published-print":{"date-parts":[[2015,9]]},"DOI":"10.1016\/j.rmed.2015.07.004","type":"journal-article","created":{"date-parts":[[2015,7,10]],"date-time":"2015-07-10T04:47:13Z","timestamp":1436503633000},"page":"1174-1180","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":65,"title":["Serum cytokine profiles of patients with interstitial lung disease associated with anti-CADM-140\/MDA5 antibody positive amyopathic dermatomyositis"],"prefix":"10.1016","volume":"109","author":[{"given":"Toshinori","family":"Takada","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ami","family":"Aoki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katsuaki","family":"Asakawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takuro","family":"Sakagami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Moriyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ichiei","family":"Narita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinji","family":"Sato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.rmed.2015.07.004_bib1","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/S0140-6736(03)14368-1","article-title":"Polymyositis and dermatomyositis","volume":"362","author":"Dalakas","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.rmed.2015.07.004_bib2","doi-asserted-by":"crossref","first-page":"3439","DOI":"10.1002\/art.30513","article-title":"Short-term and long-term outcomes of interstitial lung disease in polymyositis and dermatomyositis: a series of 107 patients","volume":"63","author":"Marie","year":"2011","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.rmed.2015.07.004_bib3","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1067\/mjd.2003.199","article-title":"Potentially fatal interstitial lung disease can occur in clinically amyopathic dermatomyositis","volume":"48","author":"Sontheimer","year":"2003","journal-title":"J.\u00a0Am. Acad. Dermatol."},{"key":"10.1016\/j.rmed.2015.07.004_bib4","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1183\/09031936.06.00038806","article-title":"Interstitial lung diseases associated with amyopathic dermatomyositis","volume":"28","author":"Suda","year":"2006","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.rmed.2015.07.004_bib5","doi-asserted-by":"crossref","first-page":"838","DOI":"10.2169\/internalmedicine.43.838","article-title":"Nonspecific interstitial pneumonia with poor prognosis associated with amyopathic dermatomyositis","volume":"43","author":"Sakamoto","year":"2004","journal-title":"Intern. Med."},{"key":"10.1016\/j.rmed.2015.07.004_bib6","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1067\/S0190-9622(03)01482-8","article-title":"Fatal interstitial pulmonary fibrosis in anti-Jo-1-negative amyopathic dermatomyositis","volume":"49","author":"High","year":"2003","journal-title":"J.\u00a0Am. Acad. Dermatol."},{"key":"10.1016\/j.rmed.2015.07.004_bib7","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1093\/rheumatology\/keh723","article-title":"Interstitial lung disease in patients with polymyositis, dermatomyositis and amyopathic dermatomyositis","volume":"44","author":"Kang","year":"2005","journal-title":"Rheumatol. Oxf."},{"key":"10.1016\/j.rmed.2015.07.004_bib8","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1002\/art.21023","article-title":"Autoantibodies to a 140-kd polypeptide, CADM-140, in Japanese patients with clinically amyopathic dermatomyositis","volume":"52","author":"Sato","year":"2005","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.rmed.2015.07.004_bib9","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.1002\/art.24621","article-title":"RNA helicase encoded by melanoma differentiation-associated gene 5 is a major autoantigen in patients with clinically amyopathic dermatomyositis: association with rapidly progressive interstitial lung disease","volume":"60","author":"Sato","year":"2009","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.rmed.2015.07.004_bib10","doi-asserted-by":"crossref","first-page":"625","DOI":"10.3109\/s10165-011-0558-9","article-title":"Amyopathic dermatomyositis developing rapidly progressive interstitial lung disease with elevation of anti-CADM-140\/MDA5 autoantibodies","volume":"22","author":"Sato","year":"2012","journal-title":"Mod. Rheumatol."},{"key":"10.1016\/j.rmed.2015.07.004_bib11","doi-asserted-by":"crossref","first-page":"496","DOI":"10.3109\/s10165-012-0663-4","article-title":"Anti-CADM-140\/MDA5 autoantibody titer correlates with disease activity and predicts disease outcome in patients with dermatomyositis and rapidly progressive interstitial lung disease","volume":"23","author":"Sato","year":"2013","journal-title":"Mod. Rheumatol."},{"key":"10.1016\/j.rmed.2015.07.004_bib12","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1093\/rheumatology\/ker408","article-title":"Disappearance of anti-MDA-5 autoantibodies in clinically amyopathic DM\/interstitial lung disease during disease remission","volume":"51","author":"Muro","year":"2012","journal-title":"Rheumatol. Oxf."},{"key":"10.1016\/j.rmed.2015.07.004_bib13","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1093\/rheumatology\/ker518","article-title":"The diagnostic utility of anti-melanoma differentiation-associated gene 5 antibody testing for predicting the prognosis of Japanese patients with DM","volume":"51","author":"Koga","year":"2012","journal-title":"Rheumatol. Oxf."},{"key":"10.1016\/j.rmed.2015.07.004_bib14","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1093\/rheumatology\/kes102","article-title":"Anti-MDA5 antibody, ferritin and IL-18 are useful for the evaluation of response to treatment in interstitial lung disease with anti-MDA5 antibody-positive dermatomyositis","volume":"51","author":"Gono","year":"2012","journal-title":"Rheumatol. Oxf."},{"key":"10.1016\/j.rmed.2015.07.004_bib15","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1002\/acr.21728","article-title":"Clinical manifestations of dermatomyositis and clinically amyopathic dermatomyositis patients with positive expression of anti-melanoma differentiation-associated gene 5 antibody","volume":"64","author":"Cao","year":"2012","journal-title":"Arthritis Care Res."},{"key":"10.1016\/j.rmed.2015.07.004_bib16","doi-asserted-by":"crossref","first-page":"963","DOI":"10.3899\/jrheum.101220","article-title":"Anti-CADM-140 antibody-positive juvenile dermatomyositis with rapidly progressive interstitial lung disease and cardiac involvement","volume":"38","author":"Sakurai","year":"2011","journal-title":"J.\u00a0Rheumatol."},{"key":"10.1016\/j.rmed.2015.07.004_bib17","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.jpeds.2010.11.033","article-title":"Anti-melanoma differentiation-associated gene 5 antibody is a diagnostic and predictive marker for interstitial lung diseases associated with juvenile dermatomyositis","volume":"158","author":"Kobayashi","year":"2011","journal-title":"J.\u00a0Pediatr."},{"key":"10.1016\/j.rmed.2015.07.004_bib18","doi-asserted-by":"crossref","first-page":"R138","DOI":"10.1186\/ar4600","article-title":"Anti-MDA5 autoantibodies in juvenile dermatomyositis identify a distinct clinical phenotype: a prospective cohort study","volume":"16","author":"Tansley","year":"2014","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.rmed.2015.07.004_bib19","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.jaad.2010.09.016","article-title":"The mucocutaneous and systemic phenotype of dermatomyositis patients with antibodies to MDA5 (CADM-140): a retrospective study","volume":"65","author":"Fiorentino","year":"2011","journal-title":"J.\u00a0Am. Acad. Dermatol."},{"key":"10.1016\/j.rmed.2015.07.004_bib20","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1002\/acr.22498","article-title":"Cutaneous ulceration in dermatomyositis: association with anti-melanoma differentiation-associated gene 5 antibodies and interstitial lung disease","volume":"67","author":"Narang","year":"2015","journal-title":"Arthritis Care Res."},{"key":"10.1016\/j.rmed.2015.07.004_bib21","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1038\/ng.2933","article-title":"Gain-of-function mutations in IFIH1 cause a spectrum of human disease phenotypes associated with upregulated type I interferon signaling","volume":"46","author":"Rice","year":"2014","journal-title":"Nat. Genet."},{"key":"10.1016\/j.rmed.2015.07.004_bib22","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1056\/NEJM197502132920706","article-title":"Polymyositis and dermatomyositis (first of two parts)","volume":"292","author":"Bohan","year":"1975","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.rmed.2015.07.004_bib23","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.cyto.2014.11.026","article-title":"The role of type I interferons and other cytokines in dermatomyositis","volume":"73","author":"Arshanapalli","year":"2015","journal-title":"Cytokine"},{"key":"10.1016\/j.rmed.2015.07.004_bib24","doi-asserted-by":"crossref","first-page":"2196","DOI":"10.1093\/rheumatology\/keu258","article-title":"Cytokine profiles in polymyositis and dermatomyositis complicated by rapidly progressive or chronic interstitial lung disease","volume":"53","author":"Gono","year":"2014","journal-title":"Rheumatol. Oxf."},{"key":"10.1016\/j.rmed.2015.07.004_bib25","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1084\/jem.20080091","article-title":"Length-dependent recognition of double-stranded ribonucleic acids by retinoic acid-inducible gene-I and melanoma differentiation-associated gene 5","volume":"205","author":"Kato","year":"2008","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.rmed.2015.07.004_bib26","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.immuni.2013.12.014","article-title":"Autoimmune disorders associated with gain of function of the intracellular sensor MDA5","volume":"40","author":"Funabiki","year":"2014","journal-title":"Immunity"},{"key":"10.1016\/j.rmed.2015.07.004_bib27","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1111\/j.1365-2249.2012.04638.x","article-title":"Type I interferon induces CX3CL1 (fractalkine) and CCL5 (RANTES) production in human pulmonary vascular endothelial cells","volume":"170","author":"Nakano","year":"2012","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.rmed.2015.07.004_bib28","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1038\/385640a0","article-title":"A\u00a0new class of membrane-bound chemokine with a CX3C motif","volume":"385","author":"Bazan","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.rmed.2015.07.004_bib29","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/S0092-8674(00)80438-9","article-title":"Identification and molecular characterization of fractalkine receptor CX3CR1, which mediates both leukocyte migration and adhesion","volume":"91","author":"Imai","year":"1997","journal-title":"Cell"},{"key":"10.1016\/j.rmed.2015.07.004_bib30","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1159\/000015000","article-title":"Human chemokines fractalkine (SCYD1), MDC (SCYA22) and TARC (SCYA17) are clustered on chromosome 16q13","volume":"81","author":"Nomiyama","year":"1998","journal-title":"Cytogenet. Cell Genet."},{"key":"10.1016\/j.rmed.2015.07.004_bib31","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1016\/S1471-4906(01)02051-8","article-title":"Fractalkine and vascular injury","volume":"22","author":"Umehara","year":"2001","journal-title":"Trends Immunol."},{"key":"10.1016\/j.rmed.2015.07.004_bib32","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1002\/1529-0131(200107)44:7<1568::AID-ART280>3.0.CO;2-1","article-title":"Fractalkine, a novel chemokine in rheumatoid arthritis and in rat adjuvant-induced arthritis","volume":"44","author":"Ruth","year":"2001","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.rmed.2015.07.004_bib33","doi-asserted-by":"crossref","first-page":"4205","DOI":"10.4049\/jimmunol.0903212","article-title":"Characterization of synergistic induction of CX3CL1\/fractalkine by TNF-alpha and IFN-gamma in vascular endothelial cells: an essential role for TNF-alpha in post-transcriptional regulation of CX3CL1","volume":"184","author":"Matsumiya","year":"2010","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.rmed.2015.07.004_bib34","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1124\/mol.106.022392","article-title":"Resveratrol suppresses tumor necrosis factor-alpha-induced fractalkine expression in endothelial cells","volume":"70","author":"Moon","year":"2006","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.rmed.2015.07.004_bib35","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.3899\/jrheum.081074","article-title":"Correlation of CX3CL1 and CX3CR1 levels with response to infliximab therapy in patients with rheumatoid arthritis","volume":"36","author":"Odai","year":"2009","journal-title":"J.\u00a0Rheumatol."},{"key":"10.1016\/j.rmed.2015.07.004_bib36","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1002\/art.1780400614","article-title":"The synovial expression and serum levels of interleukin-6, interleukin-11, leukemia inhibitory factor, and oncostatin M in rheumatoid arthritis","volume":"40","author":"Okamoto","year":"1997","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.rmed.2015.07.004_bib37","doi-asserted-by":"crossref","first-page":"R48","DOI":"10.1186\/ar3761","article-title":"Serum level of soluble CX3CL1\/fractalkine is elevated in patients with polymyositis and dermatomyositis, which is correlated with disease activity","volume":"14","author":"Suzuki","year":"2012","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.rmed.2015.07.004_bib38","first-page":"64","article-title":"Synergistic induction of CX3CL1 by interleukin-1beta and interferon-gamma in human lung fibroblasts: involvement of signal transducer and activator of transcription 1 signaling pathways","volume":"157","author":"Isozaki","year":"2011","journal-title":"Transl. Res. J. Lab. Clin. Med."},{"key":"10.1016\/j.rmed.2015.07.004_bib39","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1136\/ard.2003.018705","article-title":"Up regulated expression of fractalkine\/CX3CL1 and CX3CR1 in patients with systemic sclerosis","volume":"64","author":"Hasegawa","year":"2005","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.rmed.2015.07.004_bib40","doi-asserted-by":"crossref","first-page":"435","DOI":"10.3899\/jrheum.120725","article-title":"Serum interleukin 6 is predictive of early functional decline and mortality in interstitial lung disease associated with systemic sclerosis","volume":"40","author":"De Lauretis","year":"2013","journal-title":"J.\u00a0Rheumatol."},{"key":"10.1016\/j.rmed.2015.07.004_bib41","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1164\/ajrccm.164.7.2103110","article-title":"Polymyositis-dermatomyositis-associated interstitial lung disease","volume":"164","author":"Douglas","year":"2001","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.rmed.2015.07.004_bib42","doi-asserted-by":"crossref","first-page":"243","DOI":"10.3109\/s10165-011-0502-z","article-title":"Diffuse alveolar damage in patients with dermatomyositis: a six-case series","volume":"22","author":"Matsuki","year":"2012","journal-title":"Mod. Rheumatol."}],"container-title":["Respiratory Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0954611115300202?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0954611115300202?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T11:33:34Z","timestamp":1760614414000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0954611115300202"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,9]]},"references-count":42,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2015,9]]}},"alternative-id":["S0954611115300202"],"URL":"https:\/\/doi.org\/10.1016\/j.rmed.2015.07.004","relation":{},"ISSN":["0954-6111"],"issn-type":[{"value":"0954-6111","type":"print"}],"subject":[],"published":{"date-parts":[[2015,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Serum cytokine profiles of patients with interstitial lung disease associated with anti-CADM-140\/MDA5 antibody positive amyopathic dermatomyositis","name":"articletitle","label":"Article Title"},{"value":"Respiratory Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rmed.2015.07.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}